This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Contrast Media Injectors Market

Contrast Media Injectors Infusing New Trends in the Healthcare Sector. FMI Detects its Effect in All Major Economies.

Contrast Media Injectors Market Analysis by Product Type, by End User, and by Region | Forecast for 2023 to 2033

Contrast Media Injectors Market Snapshot (2023 to 2033)

The global contrast media injectors market was valued at US$ 1.5 Billion in 2022 and is expected to reach US$ 3 Billion by 2033, finds Future Market Insights (FMI) in a recent market survey.

The growing prevalence of trauma cases and the rising number of radiology procedures using contrast media are the primary factors boosting the demand for contrast media injectors. Also, the increase in the geriatric population and the growth of diagnostic imaging centers have strengthened the market for contrast media injectors.

The use of contrast media in radiology to enhance image quality while diagnosing a tumor is projected to develop significantly in the future. All these factors, along with the increasing prevalence of cancer worldwide, are expected to drive market growth further in the projected period.

The contrast media injectors market holds nearly 4.2% market share of the diagnostic imaging market, which was US$ 36.1 Billion in 2021. In addition, increasing awareness among physicians regarding patient safety during contrast media insertion is forcing market players to upgrade safety parameters in contrast media injectors.

Strengthening the supply chain, particularly in regions such as the Asia Pacific and the Middle East, and Africa, is the key focus area for players in this market. There is an increasing necessity to ensure the supply of the best contrast media products, as quality is of utmost importance to end users.

Governments are providing ample funding for diagnostic imaging services, with funding increasing each year substantially for healthcare facilities to adopt modern equipment. The market is also expanding owing to increasing applications of diagnostic imaging in the field of radiology and image-guided minimally invasive surgery.

Data Points

Market Insights

Market Value 2022

USD 1.5 Billion

Market Value 2023

USD 1.6 Billion

Market Value 2033

USD 3.0 Billion

CAGR 2023 to 2033

6.6%

Key Players

The key players are Bayer AG, NemotoKyorindo Co. Ltd., Mallinckrodt, Bracco Imaging, Ulrich GmBh, Guerbet SA, Medtron AG,

Share of Top 5 Countries

58.1%

The rising BPS value for the contrast media injectors market can be ascribed to the growing demand for minimally invasive procedures. There has also been a significant increase in finance and grants necessary to improve existing product lines.

The global contrast media injectors market is influenced by quality and safety regulations and licensure. Macroeconomic, regulatory, and industrial variables all have an impact on the market.

The Imaging Bulk Package (IBP), a multi-patient, multi-dose compliant contrast medium, was approved by the FDA for POC usage in the CT suite. It was created to improve safety and workflow while reducing risk and preserving compliance with multi-dose CT contrast media as a key market development factor.

Other market segments, on the other hand, are expected to perform objectively over the first half of the forecast period. Later these are expected to achieve lucrative growth prospects in the second half, especially with the development of CT and MRI contrasting agents.

Customize this Report

Let us know your requirement to get
100% FREE customization

Global Contrast Media Injectors Market Historical Analysis (2016 to 2022) Vs. Forecast Outlook (2023 to 2033)

Sales of contrast media injectors registered a CAGR of 5.5% between 2016 and 2022. Covid-19 had a significant influence on the contrast media injector market in 2020, with sales dropping by roughly 20%. By 2022, the market is expected to return to its previous highs.

The primary factors boosting the market are the rising number of radiology procedures using contrast media for reducing human error and increasing patient safety. So, healthcare professionals make it compulsory to undergo radiological testing with contrast media to come on any closing statement for any disease.

Most hospitals and ambulatory surgical centers do the radiological procedures using contrast media for patients with chronic diseases, accidents, and autoimmune diseases. Currently, some advanced contrast media injectors are available in the market that can be connected to the hospital’s IT system. It helps to directly access data from the hospital information systems (HIS) or electronic medical record (EMR) systems to adjust the dose.

This has created opportunities for leading players to come up with innovative ideas and bloom the market. Considering this, FMI expects the global contrast media injectors market to register a CAGR of 6.6% through 2033.

Major Factors Restraining the Demand for Contrast Media Injectors

The worldwide revenue growth of the contrast media injectors market is projected to be hampered by adverse consequences associated with air emboli. Air emboli formation, which arises from a major air infusion that generates an airlock in the pulmonary artery, causes blood pressure to drop quickly. It is followed by cardiovascular collapse, which is a major problem encountered during contrast media injection.

The rising cost of contrast media injectors is likely to restrict market growth throughout the forecast period, as many hospitals are unable to purchase them. Also, the demand for creative advancements, in contrast, to media injectors, has resulted in a significant increase in the price of CT and MRI injectors. Such developments have limited the sale of contrast media injectors to facilities without ample funding.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Category-wise Insights

Demand for CT Injectors continues Gaining Traction

By Product, CT Injectors are anticipated to hold the maximum share of 43.0% in 2022 owing to their ability to aid in 3D visual reconstruction.

CT injectors are used to inject iodine-based contrast media for computed tomography procedures. The adoption of CT injectors for the insertion of contrast media for various procedures such as X-ray and ultrasound is increasing. CT injectors are used to enhance image quality while also increasing patient safety.

The hospitals segment Projected Maximum Growth in the Sales of Contrast Media Injectors

Among the end-user verticals, the Hospital pharmacies segment is anticipated to hold the maximum share of 49.4% in 2022.

Hospitals have access to modern medical technology, and their infrastructure is capable of delivering high-quality care for any disease condition. Hospitals are expected to account for a significant portion of the market, as the majority of people prefer to visit hospitals for any health-related issue.

Additionally, the expanding number of hospitals and increased accessibility in emerging countries are expected to provide profitable prospects for this segment to grow further.

Comparative View of Adjacent Contrast Media Injectors Market

Contrast Media Injectors Market:

Attributes

Contrast Media Injectors Market

CAGR (2023 to 2033)

6.6%

Market Value (2023)

US$ 1.6 Billion

Growth Factor

Growing cases of radiology procedures during trauma cases.

Future Opportunities

The increasing popularity of minimally invasive procedures in almost all diseases.

Market Trends

Manufacturers are coming up with new products to remain competitive.

Therapeutic Respiratory Devices Market:

Attributes

Therapeutic Respiratory Devices Market

CAGR (2023 to 2033)

8.7%

Market Value (2023)

US$ 24.2 Billion

Growth Factor

Growing cases of COPD, Asthma, TB, and others.

Future Opportunities

An increasing percentage of aged people in the western economies.

Market Trends

Manufacturers are collaborating with NGOs and Government bodies.

Intraosseous Infusion Devices Market:

Attributes

Intraosseous Infusion Devices Market

CAGR (2023 to 2033)

6.9%

Market Value (2023)

US$ 4.4 Billion

Growth Factor

Rising number of casualty cases in the hospitals.

Future Opportunities

Improving awareness of patients as well as healthcare professionals.

Market Trends

The long-term partnership of product vendors and military healthcare facilities.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Country-wise Insights

Countries

CAGR (2023 to 2033)

The USA

6.8%

The United Kingdom

6.4%

Germany

6.3%

China

7.8%

India

5.4%

The United States Dominates the Contrast Media Injectors Market

Attributes

Details

Market Size (2033)

US$ 967.4 Million

Market Absolute Dollar Growth (US$ Million/Billion)

US$ 467.3 Million

The USA is estimated to account for around 89.5% of the North American contrast media injectors market in 2023.

The USA dominates the contrast media injectors market owing to favorable reimbursement policies and a higher percentage of the aging population in the country. Further, the rise in the regulatory approval of an increasing number of contrast agents and increasing government funding have strengthened the emerging trends.

The healthcare business in the USA is one of the well-known markets in terms of product accessibility and innovations. Trauma cases are also one of the major reasons driving the demand for contrast media injectors in Hospitals in the USA. According to the American Association for the Surgery of Trauma reported data, in 2020, trauma accounted for nearly 40 Million homicide and suicide deaths each year.

Furthermore, the presence of more IT-enabled solutions in USA Hospitals can provide additional potential development prospects for this market.

Germany is the Leading Contrast media injectors Market in European Region

Attributes

Details

Market Size (2033)

US$ 202.9 Million

Market Absolute Dollar Growth (US$ Million/Billion)

US$ 92.3 Million

Germany is estimated to account for 25.8% of the Western Europe contrast media injectors market in 2022, as a result of its well-established healthcare infrastructure.

An increase in the incidence of chronic illnesses as a consequence of changing lifestyles has strengthened the German contrast media injectors market. Furthermore, the demand for contrast media injectors in Germany is getting fueled by rising demand for minimally invasive treatments and medical tourism.

China to Outcompete All Other Countries in the Production of Contrast Media Injectors

Attributes

Details

Market Size (2033)

US$ 192.3 Million

Market Absolute Dollar Growth (US$ Million/Billion)

US$ 101.6 Million

The contrast media injectors market in China is estimated to be worth 53.1% market share in 2022 in the Asia Pacific excluding Japan (APEJ) market. The market in China is further projected to witness the highest growth rate owing to increased Research and Development (R&D) investments and a favorable demographic scenario.

The growing demand for quality healthcare facilities and the high patient population with chronic diseases are the major factors driving the sales of contrast media injectors. Being an emerging country, China is also expected to provide enormous opportunities for manufacturers to expand their business in this sector.

According to a report by WHO, in 2020, non-communicable diseases accounted for 80% of total deaths and 70% of disability-adjusted life years lost in China. This is a situation where diagnosis plays an important role and is expected to lead the contrast media injectors market growth in China.

Sales of Contrast Media Injectors in India to Rise During the Later Part of the Forecast Period

Attributes

Details

Market Size (2033)

US$ 42.5 Million

Market Absolute Dollar Growth (US$ Million/Billion)

US$ 17.5 Million

The contrast media injectors market in India is expected to have a nearly 15.0% share in the Asia Pacific market in the years following 2022.

The expansion of this sector is being driven by increased government assistance to boost healthcare infrastructure and medical service delivery. Besides, increased investment in the Indian radiology industry and increased emphasis on market participants have strengthened the market over the years.

India is anticipated to grow at an impressive rate as patients are searching for low-cost diagnoses with outpatient imaging. Demand for outpatient imaging is continuously increasing because diagnostic centers offer more relaxed, personalized service and liberties which are more accepted by the patient. CT and MRI growth have been exceptional and are increasing at a rate of about 200% over the past 10 years.

Competitive Landscape

Companies operating in the contrast media injectors market are getting competitive with the entry of many new players in the last few years. Moreover, the existing players are involved in a number of strategic alliances to expand their distribution network and remain competitive against their rivals.

The contrast media injector’s market players are trying out every possible mode of organic and inorganic growth to sustain themselves in the market. New product launches accelerate the injector manufacturer’s strategy to capitalize on market trends and capture a significant share of the market.

Scope of the Report

Attribute

Details

Forecast Period

2016 to 2022

Historical Data Available for

2023 to 2033

Market Analysis

USD Billion for Value and Units for Volume

Key Countries Covered

 The USA, Canada, Brazil, Mexico, Germany, The United Kingdom, France, Italy, Spain, Poland, Russia, Greater China, Japan, India, Australia, New Zealand, GCC Countries, South Africa

Key Segments Covered

Product Type, End User, and Region

Key Companies Profiled

  • Mallinckrodt (Guerbet SA)
  • GE Healthcare
  • Bayer AG
  • Ulrich GmbH & Co. KG
  • Bracco Imaging S.p.A
  • Medtron
  • NemotoKyorindo Co. Ltd
  • Shenzhen Anke High-tech Co. Ltd
  • Sino Medical-device Technology Co., Ltd
  • Apollo RT Co., Ltd

Report Coverage

Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Contrast Media Injectors Market by Category

By Product Type:

  • CT Injectors
  • MRI Injectors
  • Cardio Injectors

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostics Centers
  • Others

By Region:

  • North America
  • Latin America
  • Eastern Europe
  • Western Europe
  • Asia Pacific excluding Japan
  • Japan
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global contrast media injectors market is to grow at 6.6% during the forecast period.

The global contrast media injectors market is predicted to be valued at US$ 3 billion by 2033.

The global contrast media injectors market was valued at US$ 1.5 billion in 2022.

The USA accounts for 32.5% of the global revenue share in the year 2023.

China is predicted to witness the highest CAGR of 7.8% in the contrast media injectors market.

Table of Content

1. Executive Summary | Contrast Media Injectors Market

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Analysis 2017 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ million) & Volume (Units) Analysis, 2017 to 2022

    4.2. Current and Future Market Size Value (US$ million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Product, 2017 to 2022

    5.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033

        5.3.1. CT Injectors

        5.3.2. MRI Injectors

        5.3.3. Cardio Injectors

    5.4. Y-o-Y Growth Trend Analysis By Product, 2017 to 2022

    5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033

6. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By End User

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By End User, 2017 to 2022

    6.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033

        6.3.1. Hospitals

        6.3.2. Ambulatory Surgical Centers

        6.3.3. Diagnostics Centers

    6.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2022

    6.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033

7. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Region, 2017 to 2022

    7.3. Current Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Western Europe

        7.3.4. Eastern Europe

        7.3.5. APEJ

        7.3.6. Japan

        7.3.7. Middle East and Africa (MEA)

    7.4. Market Attractiveness Analysis By Region

8. North America Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    8.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1. The USA

            8.2.1.2. Canada

        8.2.2. By Product

        8.2.3. By End User

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Product

        8.3.3. By End User

    8.4. Key Takeaways

9. Latin America Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    9.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Product

        9.2.3. By End User

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Product

        9.3.3. By End User

    9.4. Key Takeaways

10. Western Europe Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    10.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. France

            10.2.1.2. Germany

            10.2.1.3. Italy

            10.2.1.4. Spain

            10.2.1.5. The United Kingdom

            10.2.1.6. Rest of Western Europe

        10.2.2. By Product

        10.2.3. By End User

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Product

        10.3.3. By End User

    10.4. Key Takeaways

11. Eastern Europe Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    11.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Russia

            11.2.1.2. Poland

            11.2.1.3. Rest of Eastern Europe

        11.2.2. By Product

        11.2.3. By End User

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Product

        11.3.3. By End User

    11.4. Key Takeaways

12. APEJ Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    12.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. Greater China

            12.2.1.2. India

            12.2.1.3. ANZ

            12.2.1.4. Rest of APEJ

        12.2.2. By Product

        12.2.3. By End User

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Product

        12.3.3. By End User

    12.4. Key Takeaways

13. Japan Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    13.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

        13.2.2. By Product

        13.2.3. By End User

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Product

        13.3.3. By End User

    13.4. Key Takeaways

14. MEA Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2017 to 2022

    14.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Rest of MEA

        14.2.2. By Product

        14.2.3. By End User

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Product

        14.3.3. By End User

    14.4. Key Takeaways

15. Key Countries Analysis

    15.1. The USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Product

            15.1.2.2. By End User

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Product

            15.2.2.2. By End User

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Product

            15.3.2.2. By End User

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Product

            15.4.2.2. By End User

    15.5. France

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Product

            15.5.2.2. By End User

    15.6. Germany

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Product

            15.6.2.2. By End User

    15.7. Italy

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Product

            15.7.2.2. By End User

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Product

            15.8.2.2. By End User

    15.9. The United Kingdom

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Product

            15.9.2.2. By End User

    15.10. Russia

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Product

            15.10.2.2. By End User

    15.11. Poland

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Product

            15.11.2.2. By End User

    15.12. Greater China

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Product

            15.12.2.2. By End User

    15.13. India

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Product

            15.13.2.2. By End User

    15.14. ANZ

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Product

            15.14.2.2. By End User

    15.15. Japan

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Product

            15.15.2.2. By End User

    15.16. GCC Countries

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Product

            15.16.2.2. By End User

    15.17. South Africa

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Product

            15.17.2.2. By End User

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Product

        16.3.3. By End User

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Mallinckrodt

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

                17.1.1.5.2. Product Strategy

                17.1.1.5.3. Channel Strategy

        17.1.2. GE Healthcare

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

                17.1.2.5.2. Product Strategy

                17.1.2.5.3. Channel Strategy

        17.1.3. Bayer AG

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

                17.1.3.5.2. Product Strategy

                17.1.3.5.3. Channel Strategy

        17.1.4. Ulrich GmbH & Co. KG

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

                17.1.4.5.2. Product Strategy

                17.1.4.5.3. Channel Strategy

        17.1.5. Bracco Imaging S.p.A

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

                17.1.5.5.2. Product Strategy

                17.1.5.5.3. Channel Strategy

        17.1.6. Medtron

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

                17.1.6.5.2. Product Strategy

                17.1.6.5.3. Channel Strategy

        17.1.7. Nemoto Kyorindo Co. Ltd

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

                17.1.7.5.2. Product Strategy

                17.1.7.5.3. Channel Strategy

        17.1.8. Shenzhen Anke High-tech Co. Ltd

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

                17.1.8.5.2. Product Strategy

                17.1.8.5.3. Channel Strategy

        17.1.9. Sino Medical-Device Technology Co., Ltd.

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

                17.1.9.5.2. Product Strategy

                17.1.9.5.3. Channel Strategy

        17.1.10. APOLLO RT Co. Ltd.

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

                17.1.10.5.2. Product Strategy

                17.1.10.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 1: Global Value (US$ million) Forecast by Region, 2017 to 2033

Table 2: Global Volume (Units) Forecast by Region, 2017 to 2033

Table 3: Global Value (US$ million) Forecast by Product, 2017 to 2033

Table 4: Global Volume (Units) Forecast by Product, 2017 to 2033

Table 5: Global Value (US$ million) Forecast by End User, 2017 to 2033

Table 6: Global Volume (Units) Forecast by End User, 2017 to 2033

Table 7: North America Value (US$ million) Forecast by Country, 2017 to 2033

Table 8: North America Volume (Units) Forecast by Country, 2017 to 2033

Table 9: North America Value (US$ million) Forecast by Product, 2017 to 2033

Table 10: North America Volume (Units) Forecast by Product, 2017 to 2033

Table 11: North America Value (US$ million) Forecast by End User, 2017 to 2033

Table 12: North America Volume (Units) Forecast by End User, 2017 to 2033

Table 13: Latin America Value (US$ million) Forecast by Country, 2017 to 2033

Table 14: Latin America Volume (Units) Forecast by Country, 2017 to 2033

Table 15: Latin America Value (US$ million) Forecast by Product, 2017 to 2033

Table 16: Latin America Volume (Units) Forecast by Product, 2017 to 2033

Table 17: Latin America Value (US$ million) Forecast by End User, 2017 to 2033

Table 18: Latin America Volume (Units) Forecast by End User, 2017 to 2033

Table 19: Western Europe Value (US$ million) Forecast by Country, 2017 to 2033

Table 20: Western Europe Volume (Units) Forecast by Country, 2017 to 2033

Table 21: Western Europe Value (US$ million) Forecast by Product, 2017 to 2033

Table 22: Western Europe Volume (Units) Forecast by Product, 2017 to 2033

Table 23: Western Europe Value (US$ million) Forecast by End User, 2017 to 2033

Table 24: Western Europe Volume (Units) Forecast by End User, 2017 to 2033

Table 25: Eastern Europe Value (US$ million) Forecast by Country, 2017 to 2033

Table 26: Eastern Europe Volume (Units) Forecast by Country, 2017 to 2033

Table 27: Eastern Europe Value (US$ million) Forecast by Product, 2017 to 2033

Table 28: Eastern Europe Volume (Units) Forecast by Product, 2017 to 2033

Table 29: Eastern Europe Value (US$ million) Forecast by End User, 2017 to 2033

Table 30: Eastern Europe Volume (Units) Forecast by End User, 2017 to 2033

Table 31: APEJ Value (US$ million) Forecast by Country, 2017 to 2033

Table 32: APEJ Volume (Units) Forecast by Country, 2017 to 2033

Table 33: APEJ Value (US$ million) Forecast by Product, 2017 to 2033

Table 34: APEJ Volume (Units) Forecast by Product, 2017 to 2033

Table 35: APEJ Value (US$ million) Forecast by End User, 2017 to 2033

Table 36: APEJ Volume (Units) Forecast by End User, 2017 to 2033

Table 37: Japan Value (US$ million) Forecast by Country, 2017 to 2033

Table 38: Japan Volume (Units) Forecast by Country, 2017 to 2033

Table 39: Japan Value (US$ million) Forecast by Product, 2017 to 2033

Table 40: Japan Volume (Units) Forecast by Product, 2017 to 2033

Table 41: Japan Value (US$ million) Forecast by End User, 2017 to 2033

Table 42: Japan Volume (Units) Forecast by End User, 2017 to 2033

Table 43: MEA Value (US$ million) Forecast by Country, 2017 to 2033

Table 44: MEA Volume (Units) Forecast by Country, 2017 to 2033

Table 45: MEA Value (US$ million) Forecast by Product, 2017 to 2033

Table 46: MEA Volume (Units) Forecast by Product, 2017 to 2033

Table 47: MEA Value (US$ million) Forecast by End User, 2017 to 2033

Table 48: MEA Volume (Units) Forecast by End User, 2017 to 2033

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 1: Global Value (US$ million) by Product, 2023 to 2033

Figure 2: Global Value (US$ million) by End User, 2023 to 2033

Figure 3: Global Value (US$ million) by Region, 2023 to 2033

Figure 4: Global Value (US$ million) Analysis by Region, 2017 to 2033

Figure 5: Global Volume (Units) Analysis by Region, 2017 to 2033

Figure 6: Global Value Share (%) and BPS Analysis by Region, 2023 to 2033

Figure 7: Global Y-o-Y Growth (%) Projections by Region, 2023 to 2033

Figure 8: Global Value (US$ million) Analysis by Product, 2017 to 2033

Figure 9: Global Volume (Units) Analysis by Product, 2017 to 2033

Figure 10: Global Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 11: Global Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 12: Global Value (US$ million) Analysis by End User, 2017 to 2033

Figure 13: Global Volume (Units) Analysis by End User, 2017 to 2033

Figure 14: Global Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 15: Global Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 16: Global Attractiveness by Product, 2023 to 2033

Figure 17: Global Attractiveness by End User, 2023 to 2033

Figure 18: Global Attractiveness by Region, 2023 to 2033

Figure 19: North America Value (US$ million) by Product, 2023 to 2033

Figure 20: North America Value (US$ million) by End User, 2023 to 2033

Figure 21: North America Value (US$ million) by Country, 2023 to 2033

Figure 22: North America Value (US$ million) Analysis by Country, 2017 to 2033

Figure 23: North America Volume (Units) Analysis by Country, 2017 to 2033

Figure 24: North America Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 25: North America Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 26: North America Value (US$ million) Analysis by Product, 2017 to 2033

Figure 27: North America Volume (Units) Analysis by Product, 2017 to 2033

Figure 28: North America Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 29: North America Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 30: North America Value (US$ million) Analysis by End User, 2017 to 2033

Figure 31: North America Volume (Units) Analysis by End User, 2017 to 2033

Figure 32: North America Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 33: North America Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 34: North America Attractiveness by Product, 2023 to 2033

Figure 35: North America Attractiveness by End User, 2023 to 2033

Figure 36: North America Attractiveness by Country, 2023 to 2033

Figure 37: Latin America Value (US$ million) by Product, 2023 to 2033

Figure 38: Latin America Value (US$ million) by End User, 2023 to 2033

Figure 39: Latin America Value (US$ million) by Country, 2023 to 2033

Figure 40: Latin America Value (US$ million) Analysis by Country, 2017 to 2033

Figure 41: Latin America Volume (Units) Analysis by Country, 2017 to 2033

Figure 42: Latin America Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 43: Latin America Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 44: Latin America Value (US$ million) Analysis by Product, 2017 to 2033

Figure 45: Latin America Volume (Units) Analysis by Product, 2017 to 2033

Figure 46: Latin America Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 47: Latin America Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 48: Latin America Value (US$ million) Analysis by End User, 2017 to 2033

Figure 49: Latin America Volume (Units) Analysis by End User, 2017 to 2033

Figure 50: Latin America Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 51: Latin America Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 52: Latin America Attractiveness by Product, 2023 to 2033

Figure 53: Latin America Attractiveness by End User, 2023 to 2033

Figure 54: Latin America Attractiveness by Country, 2023 to 2033

Figure 55: Western Europe Value (US$ million) by Product, 2023 to 2033

Figure 56: Western Europe Value (US$ million) by End User, 2023 to 2033

Figure 57: Western Europe Value (US$ million) by Country, 2023 to 2033

Figure 58: Western Europe Value (US$ million) Analysis by Country, 2017 to 2033

Figure 59: Western Europe Volume (Units) Analysis by Country, 2017 to 2033

Figure 60: Western Europe Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 61: Western Europe Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 62: Western Europe Value (US$ million) Analysis by Product, 2017 to 2033

Figure 63: Western Europe Volume (Units) Analysis by Product, 2017 to 2033

Figure 64: Western Europe Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 65: Western Europe Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 66: Western Europe Value (US$ million) Analysis by End User, 2017 to 2033

Figure 67: Western Europe Volume (Units) Analysis by End User, 2017 to 2033

Figure 68: Western Europe Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 69: Western Europe Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 70: Western Europe Attractiveness by Product, 2023 to 2033

Figure 71: Western Europe Attractiveness by End User, 2023 to 2033

Figure 72: Western Europe Attractiveness by Country, 2023 to 2033

Figure 73: Eastern Europe Value (US$ million) by Product, 2023 to 2033

Figure 74: Eastern Europe Value (US$ million) by End User, 2023 to 2033

Figure 75: Eastern Europe Value (US$ million) by Country, 2023 to 2033

Figure 76: Eastern Europe Value (US$ million) Analysis by Country, 2017 to 2033

Figure 77: Eastern Europe Volume (Units) Analysis by Country, 2017 to 2033

Figure 78: Eastern Europe Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 79: Eastern Europe Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 80: Eastern Europe Value (US$ million) Analysis by Product, 2017 to 2033

Figure 81: Eastern Europe Volume (Units) Analysis by Product, 2017 to 2033

Figure 82: Eastern Europe Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 83: Eastern Europe Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 84: Eastern Europe Value (US$ million) Analysis by End User, 2017 to 2033

Figure 85: Eastern Europe Volume (Units) Analysis by End User, 2017 to 2033

Figure 86: Eastern Europe Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 87: Eastern Europe Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 88: Eastern Europe Attractiveness by Product, 2023 to 2033

Figure 89: Eastern Europe Attractiveness by End User, 2023 to 2033

Figure 90: Eastern Europe Attractiveness by Country, 2023 to 2033

Figure 91: APEJ Value (US$ million) by Product, 2023 to 2033

Figure 92: APEJ Value (US$ million) by End User, 2023 to 2033

Figure 93: APEJ Value (US$ million) by Country, 2023 to 2033

Figure 94: APEJ Value (US$ million) Analysis by Country, 2017 to 2033

Figure 95: APEJ Volume (Units) Analysis by Country, 2017 to 2033

Figure 96: APEJ Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 97: APEJ Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 98: APEJ Value (US$ million) Analysis by Product, 2017 to 2033

Figure 99: APEJ Volume (Units) Analysis by Product, 2017 to 2033

Figure 100: APEJ Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 101: APEJ Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 102: APEJ Value (US$ million) Analysis by End User, 2017 to 2033

Figure 103: APEJ Volume (Units) Analysis by End User, 2017 to 2033

Figure 104: APEJ Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 105: APEJ Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 106: APEJ Attractiveness by Product, 2023 to 2033

Figure 107: APEJ Attractiveness by End User, 2023 to 2033

Figure 108: APEJ Attractiveness by Country, 2023 to 2033

Figure 109: Japan Value (US$ million) by Product, 2023 to 2033

Figure 110: Japan Value (US$ million) by End User, 2023 to 2033

Figure 111: Japan Value (US$ million) by Country, 2023 to 2033

Figure 112: Japan Value (US$ million) Analysis by Country, 2017 to 2033

Figure 113: Japan Volume (Units) Analysis by Country, 2017 to 2033

Figure 114: Japan Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 115: Japan Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 116: Japan Value (US$ million) Analysis by Product, 2017 to 2033

Figure 117: Japan Volume (Units) Analysis by Product, 2017 to 2033

Figure 118: Japan Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 119: Japan Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 120: Japan Value (US$ million) Analysis by End User, 2017 to 2033

Figure 121: Japan Volume (Units) Analysis by End User, 2017 to 2033

Figure 122: Japan Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 123: Japan Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 124: Japan Attractiveness by Product, 2023 to 2033

Figure 125: Japan Attractiveness by End User, 2023 to 2033

Figure 126: Japan Attractiveness by Country, 2023 to 2033

Figure 127: MEA Value (US$ million) by Product, 2023 to 2033

Figure 128: MEA Value (US$ million) by End User, 2023 to 2033

Figure 129: MEA Value (US$ million) by Country, 2023 to 2033

Figure 130: MEA Value (US$ million) Analysis by Country, 2017 to 2033

Figure 131: MEA Volume (Units) Analysis by Country, 2017 to 2033

Figure 132: MEA Value Share (%) and BPS Analysis by Country, 2023 to 2033

Figure 133: MEA Y-o-Y Growth (%) Projections by Country, 2023 to 2033

Figure 134: MEA Value (US$ million) Analysis by Product, 2017 to 2033

Figure 135: MEA Volume (Units) Analysis by Product, 2017 to 2033

Figure 136: MEA Value Share (%) and BPS Analysis by Product, 2023 to 2033

Figure 137: MEA Y-o-Y Growth (%) Projections by Product, 2023 to 2033

Figure 138: MEA Value (US$ million) Analysis by End User, 2017 to 2033

Figure 139: MEA Volume (Units) Analysis by End User, 2017 to 2033

Figure 140: MEA Value Share (%) and BPS Analysis by End User, 2023 to 2033

Figure 141: MEA Y-o-Y Growth (%) Projections by End User, 2023 to 2033

Figure 142: MEA Attractiveness by Product, 2023 to 2033

Figure 143: MEA Attractiveness by End User, 2023 to 2033

Figure 144: MEA Attractiveness by Country, 2023 to 2033

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Contrast-Enhanced Ultrasound Market

Published : July 2019

Healthcare

Contrast Injection Lines Market

Published : April 2019

Google translate

Contrast Media Injectors Market